Galderma Delivers Net Sales of 4.765 B USD in the First Nine Months, Up 25.1% at Constant Currency Year-on-Year, and Raises Full-Year Net Sales Guidance

来源: 编辑: 发布: 2026-10-27 04:14

Ad hoc announcement pursuant to Art. 53 LR

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first nine months of 2026.

  • Record net sales of 4.765 billion USD for the first nine months of 2026, representing 25.1% year-on-year growth at constant currency1, predominantly driven by volume and complemented by favorable mix.
  • Broad-based double-digit growth across geographies and product categories, reflecting strong execution of Galderma’s proven integrated dermatology strategy, with stand-out performance in Therapeutic Dermatology, across both Nemluvio and the mature portfolio, as well as in Dermatological Skincare and Neuromodulators.
  • Continued market outperformance across all three product categories, with net sales growth year-on-year at constant currency of 13.2% in Injectable Aesthetics, 16.2% in Dermatological Skincare, and 64.4% in Therapeutic Dermatology (with Nemluvio net sales of 735 million USD).
  • Strengthening Galderma’s dermatology platform, with the previously announced agreement to acquire ZO® Skin Health, a leading brand in the fast-growing physician-dispensed skincare category. The transaction is expected to close in the fourth quarter of 2026 or early 2027, subject to regulatory approvals and other customary closing conditions.
  • Further evolution as a listed company, with Galderma’s inclusion in the Swiss Market Index (SMI) and an upgraded credit rating.
  • Raising 2026 full-year net sales guidance to 22.5-23.5% growth year-on-year at constant currency (previously 19-21%), and confirming Core EBITDA margin2 of approximately 26% at constant currency.

 

“Our strong performance in the first nine months of 2026 underscores the sustained momentum across our business and the strength of our integrated dermatology strategy. Robust demand for our differentiated, premium portfolio continues to drive growth, while we advance innovation and take decisive steps to strengthen our long-term growth prospects, including our agreement to acquire ZO Skin Health. Building on this momentum and our confidence in the business, we are raising our full-year net sales guidance.”

 

FLEMMING ØRNSKOV, M.D., MPH

CHIEF EXECUTIVE OFFICER

GALDERMA

 

 

猜你还想看:

网易网友:识趣 Content つ
评论:看我不顺眼的人,能给您心里添堵,我真是舒坦。

淘宝网友:他就是我的天
评论:每天都要做两件事情:晚上不想睡、早上不想起。

其它网友:陪珎﹃辈孒き
评论:一切不以睡眠为目的的度周末,都是耍流氓!

百度网友:空白  Koreyoshi
评论:想让一个人对你念念不忘的话,最好的办法就是向他借钱。

搜狐网友:血统 FackEdison◎
评论:从小就有一个敌人叫“别人家的小孩”。他不爱玩游戏,从来只知道学习。

猫扑网友:爱情° love
评论:老师说过早恋是不好的,我们很听话,只会暗恋

天涯网友:红衣a young woman
评论:快开学了,学校,你得到的我的人却得不到我的心。

本网网友:我瘋癫我快樂
评论:酒是穿肠毒药,色是刮骨钢刀,气是拦路猛虎,钱是卑贱之源

腾讯网友:人身尽情挥霍
评论:警察说:"你不知道开车不让打电话吗?"我一脸疑惑的说:"我没打电话呀?.....我发短信来着!"

凤凰网友:Pawonx-爱离殇
评论:人生为棋,我愿为卒,行动虽慢,可谁曾见我后退一步。